Nivolumab-Induced Hemophilia A Presenting as Gastric Ulcer Bleeding in a Patient With NSCLC

J Thorac Oncol. 2018 Dec;13(12):e239-e241. doi: 10.1016/j.jtho.2018.06.024. Epub 2018 Jul 12.
No abstract available

Keywords: Acquired hemophilia; Immune-related adverse event; NSCLC; Nivolumab.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents, Immunological / adverse effects
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / secondary
  • Diagnosis, Differential
  • Hemophilia A / chemically induced
  • Hemophilia A / diagnosis*
  • Hemorrhage / chemically induced
  • Hemorrhage / diagnosis*
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Male
  • Nivolumab / adverse effects*
  • Prognosis
  • Stomach Ulcer / chemically induced
  • Stomach Ulcer / diagnosis*

Substances

  • Antineoplastic Agents, Immunological
  • Nivolumab